• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《甲真菌病治疗的实用指南:如何从患者、病原体、治疗和环境层面最大化治愈率》

A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level.

机构信息

Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, ON, Canada.

Mediprobe Research Inc., 645 Windermere Road, London, ON, N5X2P1, Canada.

出版信息

Am J Clin Dermatol. 2019 Feb;20(1):123-133. doi: 10.1007/s40257-018-0403-4.

DOI:10.1007/s40257-018-0403-4
PMID:30456537
Abstract

Onychomycosis is a fungal nail infection caused by dermatophytes, non-dermatophyte molds, and yeasts. Treatment of this infection can be difficult, with relapse likely to occur within 2.5 years of cure. The objective of this article is to review factors that can impact cure and to suggest practical techniques that physicians can use to maximize cure rates. Co-morbidities, as well as disease severity and duration, are among the many patient factors that could influence the efficacy of antifungal therapies. Furthermore, organism, treatment, and environmental factors that may hinder cure include point mutations, biofilms, affinity for non-target enzymes, and exposure to fungal reservoirs. To address patient-related factors, physicians are encouraged to conduct confirmatory testing and treat co-morbidities such as tinea pedis early and completely. To combat organism-focused factors, it is recommended that disruption of biofilms is considered, and drugs with multiple routes of delivery and unique mechanisms of action are prescribed when traditional agents are not effective. Extending follow-up periods, using combination treatments, and considering pulse regimens may also be of benefit. Through these practical techniques, physicians can maximize cure and limit the risk of relapse and re-infection.

摘要

甲真菌病是一种由真菌引起的指甲感染,包括皮肤癣菌、非皮肤癣菌霉菌和酵母菌。这种感染的治疗可能很困难,治愈后 2.5 年内很可能复发。本文的目的是回顾可能影响治愈率的因素,并提出医生可以用来最大限度提高治愈率的实用技术。合并症以及疾病的严重程度和持续时间是许多可能影响抗真菌治疗效果的患者因素之一。此外,可能阻碍治愈的病原体、治疗和环境因素包括点突变、生物膜、非靶标酶亲和力和真菌库暴露。为了解决与患者相关的因素,鼓励医生进行确认性检测,并早期和彻底治疗合并的足癣。为了对抗以病原体为重点的因素,建议考虑破坏生物膜,并在传统药物无效时开具具有多种给药途径和独特作用机制的药物。延长随访期、使用联合治疗以及考虑脉冲疗法也可能有益。通过这些实用技术,医生可以最大限度地提高治愈率,并降低复发和再感染的风险。

相似文献

1
A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level.《甲真菌病治疗的实用指南:如何从患者、病原体、治疗和环境层面最大化治愈率》
Am J Clin Dermatol. 2019 Feb;20(1):123-133. doi: 10.1007/s40257-018-0403-4.
2
Fungal nail infections (onychomycosis): a never-ending story?甲真菌病:一个没完没了的故事?
PLoS Pathog. 2014 Jun 5;10(6):e1004105. doi: 10.1371/journal.ppat.1004105. eCollection 2014 Jun.
3
[Onychomycosis : a crown jewel of dermatology].[甲癣:皮肤科的一颗璀璨明珠]
Hautarzt. 2012 Nov;63(11):842-7. doi: 10.1007/s00105-012-2448-2.
4
Update on current approaches to diagnosis and treatment of onychomycosis.甲真菌病诊断和治疗方法的最新进展。
Expert Rev Anti Infect Ther. 2018 Dec;16(12):929-938. doi: 10.1080/14787210.2018.1544891. Epub 2018 Nov 13.
5
Onychomycosis: Diagnosis and management.甲真菌病:诊断与治疗。
Indian J Dermatol Venereol Leprol. 2011 Nov-Dec;77(6):659-72. doi: 10.4103/0378-6323.86475.
6
Onchomycosis: an overview.甲癣:概述。
J Drugs Dermatol. 2013 Jul 1;12(7):s96-103.
7
New antifungal therapies for the treatment of onychomycosis.用于治疗甲癣的新型抗真菌疗法。
Expert Opin Investig Drugs. 2009 Jun;18(6):727-34. doi: 10.1517/13543780902810352.
8
Today's treatments options for onychomycosis.今日甲真菌病的治疗选择。
J Dtsch Dermatol Ges. 2010 Nov;8(11):875-9. doi: 10.1111/j.1610-0387.2010.07499.x. Epub 2010 Aug 25.
9
[Treatment of onychomycosis].[甲癣的治疗]
Duodecim. 1998;22(114):2343-50.
10
Onychomycosis: An Updated Review.甲癣:最新综述
Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45. doi: 10.2174/1872213X13666191026090713.

引用本文的文献

1
Superficial Candidiasis: Cluster Analysis of Species Distribution and Their Antifungal Susceptibility In Vitro.浅部念珠菌病:菌种分布及其体外抗真菌药敏性的聚类分析
J Fungi (Basel). 2025 Apr 25;11(5):338. doi: 10.3390/jof11050338.
2
Evaluation of the efficacy and safety of ionic liquids containing ketoconazole in patients with tinea pedis: A randomized controlled clinical trial.含酮康唑离子液体治疗足癣患者的疗效和安全性评估:一项随机对照临床试验。
Bioeng Transl Med. 2022 Dec 2;8(3):e10463. doi: 10.1002/btm2.10463. eCollection 2023 May.
3
Efficacy of Bovine Nail Membranes as In Vitro Model for Onychomycosis Infected by Species.
牛指甲膜作为感染菌种的甲癣体外模型的有效性。
J Fungi (Basel). 2022 Oct 27;8(11):1133. doi: 10.3390/jof8111133.
4
A Paradigm Shift in the Treatment and Management of Onychomycosis.甲癣治疗与管理的范式转变
Skin Appendage Disord. 2021 Aug;7(5):351-358. doi: 10.1159/000516112. Epub 2021 May 11.
5
Cold atmospheric pressure plasma (CAPP) as a new alternative treatment method for onychomycosis caused by Trichophyton verrucosum: in vitro studies.冷大气压等离子体(CAPP)作为一种治疗疣状毛癣菌引起的甲真菌病的新替代治疗方法:体外研究。
Infection. 2021 Dec;49(6):1233-1240. doi: 10.1007/s15010-021-01691-w. Epub 2021 Sep 9.
6
Combination of a triple wavelength (650 nm, 810 nm, and 915 nm) class IV laser system and local mechanical abrasion in the treatment of chronic toenail onychomycosis: an uncontrolled prospective pilot study.三重波长(650nm、810nm 和 915nm)四级激光系统联合局部机械打磨治疗慢性甲真菌病的前瞻性非对照研究。
Int J Dermatol. 2022 Mar;61(3):367-371. doi: 10.1111/ijd.15869. Epub 2021 Aug 27.
7
The Success of Topical Treatment of Onychomycosis Seems to Be Influenced by Fungal Features.甲癣局部治疗的成功似乎受真菌特性影响。
Evid Based Complement Alternat Med. 2021 Jul 9;2021:5553634. doi: 10.1155/2021/5553634. eCollection 2021.
8
Human Nails Permeation of an Antifungal Candidate Hydroalcoholic Extract from the Plant L. Rich in Saponins.人指甲对富含皂苷植物 L 的抗真菌候选水醇提取物的渗透作用。
Molecules. 2021 Jan 5;26(1):236. doi: 10.3390/molecules26010236.
9
NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile.NP213(Novexatin®):一种具有差异化安全性和疗效特征的独特的甲真菌病治疗候选药物。
Med Mycol. 2020 Nov 10;58(8):1064-1072. doi: 10.1093/mmy/myaa015.
10
A Week of Oral Terbinafine Pulse Regimen Every Three Months to Treat all Dermatophyte Onychomycosis.每三个月进行一周的口服特比萘芬冲击疗法治疗所有皮肤癣菌性甲真菌病。
J Fungi (Basel). 2019 Sep 4;5(3):82. doi: 10.3390/jof5030082.